Total Payments
$9,460
2024 Payments
$1,426
Companies
64
Transactions
449
Medicare Patients
10,438
Medicare Billing
$3.7M
Payment Breakdown by Category
Food & Beverage$6,837 (72.3%)
Education$1,679 (17.7%)
Other$498.50 (5.3%)
Consulting$444.89 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,837 | 404 | 72.3% |
| Education | $1,679 | 39 | 17.7% |
| Long term medical supply or device loan | $498.50 | 5 | 5.3% |
| Consulting Fee | $444.89 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,224 | 86 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,014 | 49 | $0 (2024) |
| Janssen Biotech, Inc. | $834.91 | 32 | $0 (2024) |
| PFIZER INC. | $628.79 | 56 | $0 (2024) |
| McKesson Specialty Care Distribution Corp. | $444.89 | 1 | $0 (2017) |
| Aveo Pharmaceuticals, Inc. | $414.03 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $395.49 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $358.12 | 12 | $0 (2024) |
| Amgen Inc. | $340.05 | 16 | $0 (2022) |
| Incyte Corporation | $292.86 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,426 | 59 | PFIZER INC. ($239.43) |
| 2023 | $1,236 | 49 | Novartis Pharmaceuticals Corporation ($147.48) |
| 2022 | $1,524 | 60 | Janssen Biotech, Inc. ($196.54) |
| 2021 | $1,048 | 31 | Novartis Pharmaceuticals Corporation ($589.86) |
| 2020 | $164.51 | 9 | Janssen Biotech, Inc. ($40.00) |
| 2019 | $915.48 | 65 | Novartis Pharmaceuticals Corporation ($148.20) |
| 2018 | $1,465 | 89 | E.R. Squibb & Sons, L.L.C. ($256.06) |
| 2017 | $1,681 | 87 | McKesson Specialty Care Distribution Corp. ($444.89) |
All Payment Transactions
449 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Oncology | ||||||
| 12/11/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $42.49 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: BioOncology | ||||||
| 11/05/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/18/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.40 | General |
| 09/06/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Oncology | ||||||
| 08/30/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Oncology | ||||||
| 08/07/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 07/19/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Oncology | ||||||
| 07/17/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Oncology | ||||||
| 07/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $30.76 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $26.83 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,049 | 16,746 | $1.0M | $281,971 |
| 2022 | 37 | 2,631 | 46,913 | $2.6M | $853,610 |
| 2021 | 38 | 2,801 | 56,893 | $3.9M | $1.4M |
| 2020 | 42 | 2,957 | 61,275 | $3.5M | $1.2M |
Total Patients
10,438
Total Services
181,827
Medicare Billing
$3.7M
Procedure Codes
148
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 6,540 | $308,581 | $120,438 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 287 | 577 | $151,326 | $36,362 | 24.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 42 | 248 | $116,534 | $24,415 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 244 | $89,607 | $20,666 | 23.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 276 | 1,209 | $38,301 | $12,484 | 32.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 320 | 1,441 | $33,590 | $10,927 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 297 | 1,102 | $25,722 | $9,232 | 35.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 40 | 155 | $34,612 | $7,134 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $23,161 | $5,758 | 24.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 83 | $19,047 | $5,059 | 26.6% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 36 | 174 | $18,757 | $3,796 | 20.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 67 | $14,581 | $3,577 | 24.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 333 | $24,542 | $3,462 | 14.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 92 | $9,058 | $2,120 | 23.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 39 | 127 | $6,401 | $2,079 | 32.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 32 | 168 | $16,447 | $1,998 | 12.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 65 | 137 | $5,602 | $1,820 | 32.5% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 14 | 111 | $6,634 | $1,738 | 26.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 13 | 76 | $11,286 | $1,651 | 14.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 21 | 89 | $4,910 | $1,604 | 32.7% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 16 | 217 | $42,779 | $1,395 | 3.3% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 11 | 27 | $9,890 | $1,314 | 13.3% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 70 | 126 | $2,283 | $745.92 | 32.7% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 14 | 33 | $1,877 | $613.14 | 32.7% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 13 | 610 | $22,070 | $481.20 | 2.2% |
About Dr. William Pierce, M.D
Dr. William Pierce, M.D is a Hematology & Oncology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184718314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Pierce, M.D has received a total of $9,460 in payments from pharmaceutical and medical device companies, with $1,426 received in 2024. These payments were reported across 449 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($6,837).
As a Medicare-enrolled provider, Pierce has provided services to 10,438 Medicare beneficiaries, totaling 181,827 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology
- Location Salem, OR
- Active Since 10/03/2006
- Last Updated 07/08/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1184718314
Products in Payments
- OPDIVO (Biological) $665.62
- KISQALI (Drug) $588.94
- IMBRUVICA (Drug) $424.08
- FOTIVDA (Drug) $414.03
- KEYTRUDA (Biological) $276.21
- DARZALEX (Biological) $251.40
- SARCLISA (Biological) $238.60
- PROMACTA (Drug) $233.80
- VELCADE (Drug) $211.19
- ELIQUIS (Drug) $183.04
- ZEJULA (Drug) $162.91
- BOSULIF (Drug) $160.73
- Xospata (Drug) $132.89
- SCEMBLIX (Drug) $131.28
- MONJUVI (Drug) $114.73
- TIVDAK (Biological) $111.24
- OPDUALAG (Drug) $107.62
- Kyprolis (Biological) $104.79
- LIBTAYO (Biological) $103.68
- Doptelet (Drug) $99.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Salem
Igor Genkin, Md, MD
Hematology & Oncology — Payments: $37,121
Hematology & Oncology $37,121
Dr. Paul Richards, M.d, M.D
Hematology & Oncology — Payments: $29,258
Hematology & Oncology $29,258
Dr. Vandana Karri, Md, MD
Hematology & Oncology — Payments: $15,833
Hematology & Oncology $15,833
Dr. Mark Currie, M.d, M.D
Hematology & Oncology — Payments: $15,478
Hematology & Oncology $15,478
Janelle Meyer, Md, MD
Hematology & Oncology — Payments: $7,484
Hematology & Oncology $7,484
John Strother, M.d, M.D
Hematology & Oncology — Payments: $3,216
Hematology & Oncology $3,216